Mydecine Innovations Group Inc.
MYCOF
$0.0045
-$0.0006-11.77%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.13% | -27.28% | -23.65% | -250.82% | 41.48% |
| Total Depreciation and Amortization | -100.00% | -92.91% | -90.76% | -90.97% | -91.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 639.98% | 550.87% | 414.63% | 275.91% | -122.73% |
| Change in Net Operating Assets | -5.43% | -3.47% | 31.59% | -6.84% | 186.30% |
| Cash from Operations | 119.01% | 117.71% | 100.93% | 60.07% | 54.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -94.50% | 1,502.53% | 631.37% |
| Cash from Investing | -100.00% | -100.00% | -94.26% | 699.54% | 447.59% |
| Total Debt Issued | 7.11% | 7.11% | 307.41% | -42.29% | -98.16% |
| Total Debt Repaid | -- | -- | -- | -- | -42.25% |
| Issuance of Common Stock | -- | -99.98% | -90.24% | -47.39% | -29.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 91.08% |
| Cash from Financing | -120.42% | -120.40% | -101.17% | -59.97% | -54.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 159.51% | 43.50% | 165.49% | 102.01% | 94.76% |
